The Indianapolis-based medical school ranked 29th in the country for landing funding from the National Institutes of Health.
Read More
The IU School of Medicine scored a major coup five years ago when it recruited one of the nation’s top experts in the fast-growing field of regenerative medicine. But the University of Pittsburgh recruited him away this spring.
Read More
Fred Cate, IU’s vice president for research, informed federal officials that the research group had “a pattern of non-compliance” and had been warned several times against using expired materials.
Read More
The money will be used to provide new opportunities for graduate students typically underrepresented in biomedical science, officials said.
Read More
The lab, which will be located on the second floor of the 11-story IU Medical Education and Research Building, will emphasize hands-on physical dissection as a vital component of medical training.
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
There have been only a handful of previous $1 billion donations to universities in the U.S., most coming in the past several years.
Dr. Rachel Patzer, director of the Health Services Research Center at the Emory University School of Medicine in Atlanta, will join Regenstrief Institute on May 1.
The not-for-profit Tumaini Foundation for Global Health and Humanitarianism says it wants to train medical students with a special concern for the health of needy individuals and populations worldwide.
The high-tech approach allows a patient recovering from substance abuse to interact with potential future versions of himself or herself.
The medical school said the commitment will help launch research efforts to develop better therapies for triple negative breast cancer, an aggressive form of breast cancer that is often not responsive to hormone therapies and is resistant to chemotherapy.
IU said the 11-story, 325,000-square-foot facility in Indianapolis will be used to address instructional and research needs of programs in the university’s school of medicine.
Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.
Speakers at the IBJ Life Sciences Power Panel on Friday said their organizations have largely weathered the lockdown—raising records funds, taking on huge expansions, hiring new employees and reporting higher productivity.
The center, which is home to one of the medical school’s largest programs, will move from its current location at Senate Avenue and 15th Street to the IUPUI campus.
In 1879, Dr. William N. Wishard, then 27 years old, became superintendent of Indianapolis City Hospital, an institution so little regarded that it lacked city water and gas.
The move will uproot much of the medical school traditional operations. All classroom instruction for medical students will go to the new campus, as will graduate training programs in the clinical sciences for residents and fellows.
Some of the vaccine trials in the United States are taking place at Indiana University School of Medicine in Indianapolis.
Just 12 years after opening to great fanfare, the future of the $150 million center, a partnership between the Indiana University School of Medicine and Indiana University Health, is full of questions.
The grant will help fund an ongoing study to evaluate long-term health outcomes for cancer patients who receive life-saving chemotherapy treatments that often have difficult side effects.
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.
The trials, which will begin in 2020, are part of a sweeping, five-year, $42 million federal research program known as Implementing Genomics in Practice. The first trial will examine whether early access to patients’ genomic data can help with treatment of high blood pressure, hypertension and chronic kidney disease.
The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.
